Clustering of hypermethylated genes in neuroblastoma

Genes Chromosomes and Cancer

Volumn 38, Issue 3, 2003, Pages 226-233

  Van Noesel, Max M ^a,b,c   Van Bezouw, Saskia ^a   Voute P A ^a   Herman, James G ^b   Pieters, Rob ^c   Versteeg, Rogier ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FLICE INHIBITORY PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN DCR1; PROTEIN DCR2; PROTEIN DCR4; PROTEIN DCR5; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 2Q; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE CLUSTER; GENE DUPLICATION; GENE INACTIVATION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY;

ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CELL LINE, TUMOR; CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MULTIGENE FAMILY; NEUROBLASTOMA; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

EID: 0141993688     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10278     Document Type: Article

References (23)

1. Breit S, Ashman K, Wilting J, Rossler J, Hatzi E, Fotsis T, Scliweigerer L. 2000. The MYCN oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 60:4596-4601.
2. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. 1984. Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
3. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103-107.
4. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG. 1999. Transcriptional silencing of the TP73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59:3352-3356.
5. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Brodeur GM. 2001. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61:1314-1319.
6. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
7. Goll MG, Bestor TH. 2002. Histone modification and replacement in chromatin activation. Genes Dev 16:1739-1742.
8. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. 2000. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16-17.
9. Gray SG, Teh BT. 2001. Histone acetylation/deacetylation and cancer: an "open" and "shut" case? Curr Mol Med 1:401-429.
10. Hatzi E, Murphy C, Zoephel A, Rasmussen H, Morbidelli L, Ahorn H, Kunisada K, Tontsch U, Klenk M, Yamauchi-Takihara K, Ziche M, Rofsiad EK, Schweigerer L, Fotsis T. 2002. MYCN oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene 21:3552-3561.
11. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
12. Jackson JP, Lindroth AM, Cao X, Jacobsen SE. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416:556-560.
13. Jacobs SA, Khorasanizadeh S. 2002. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 295:2080-2083.
14. Johnson L, Cao X, Jacobsen S. 2002. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr Biol 12:1360-1367.
15. Jones PA, Baylin SB. 2002. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428.
16. Mikovits JA, Young HA, Vertino P, Issa JP, Pitha PM, Turcoski-Corrales S, Taub DD, Petrow CL, Baylin SB, Ruscetti FW. 1998. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent down-regulation of IFN-gamma production. Mol Cell Biol 18:5166-5177.
17. Myohanen SK, Baylin SB, Herman JG. 1998. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58:591-593.
18. Schwab M. 2002. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology. Ann NY Acad Sci 963:63-73.
19. Tamaru H, Selker EU. 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414:277-283.
20. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529-535.
21. Teitz T, Lahti JM, Kidd VJ. 2001. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med 79:428-436.
22. van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG, Versteeg R. 2002. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DCR1 and DCR2 is associated with dense promoter hypermethylation. Cancer Res 62:2157-2161.
23. Vertino PM, Yen RW, Gao J, Baylin SB. 1996. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol 16:4555-4565.